Clinical Update: Risk of Particulate Contamination in Infusion Therapy

Start
07 Mar 2016
6:00 PM
End
08 Mar 2016
7:30 PM
Location
St. Joseph’s Hospital Room MAB 2/3/4 (Medical Arts Building) 3001 W. Dr. MLK Jr. Blvd Tampa, Florida 33607
Registered
22 registrants

Registration

Member
Non-Member – $10.00
Nursing Student (non-licensed)

Registration is closed

Speaker: Josie Stone RN, CPNP, CRNI, VA-BC

*Josie Stone has been a Registered Nurse with over 30 years of experience, practicing in many specialty areas including Neonatal Intensive Care, Neonatal Transport, Obstetrics, Pediatrics, Critical Care, and Hospital Administration. Additionally she received her Pediatric Nurse Practitioner License in 1982. She currently has her own education and consulting business.

She has been closely involved for many of those years in vascular access practice and product development, and has long been a clinical educator for this specialty area. Her initial involvement with IV catheters of all kinds started with the neonatal population but expanded though the years to all ages and she speaks on these topics to both National and International audiences.

Josie has been very involved with Vascular Access and Infusion organizations and is certified as an INS (Infusion Nurses Society) CRNI. She is a member and Past President of AVA (Association for Vascular Access) and currently serves on their Global Policy Committee.

Sponsored by our friends at PALL Medical

Objectives:

To identify the type and source of particulates in IV solutions today.
To understand the relationship between infusion-related particulates and their effect on the patient.

Key Discussion Points:

The problem
What do we know about particles?
What clinical effects do they have?
Which patients are especially vulnerable?
The value of filtration on particle related risks

Abstract: Particulate matter exists within our environment and has been well documented to cause respiratory sequelae. Particulates occur within Intravenous (IV) Solutions as well and can result in complications within the pulmonary, coronary and vasculature systems. The origin of particulate matter can be the result of drug incompatibilities, admixing, TPN delivery and lipid micelles, glass ampoule breakage, air emboli, and foreign body particles. Clinical manifestations of particulates include embolization, thrombogenic effects and inflammation. The complexity of infusion therapy increases the risk for particulate matter and requires the clinician to become knowledgeable about particulates in IV solutions in order to provide safe care to the infusion therapy patient.

This footer is displayed on all pages.
If it is empty, default text is displayed here.
Delete this text and insert your copyright text or anything else you want.